15.10.2017
Restylane® SkinboostersTM for the improvement of skin quality Results of a consensus meeting
Shirin Samimi-Fard
15.10.2017
News
20.04.2016
The sun, the main cause of occupational cancer
Brussels, Belgium/Lugano Switzerland – There are almost 14.5 million workers in Europe, who spend at least 75% of their working time under the sun. A new report published last week […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
23.09.2023
Focus on hyperpigmentation:
Treatment options and combination therapy in everyday practice Hyperpigmentation plays a major role in the daily routine of dermatologists. Solar radiation, stress and various noxae are regarded as triggers for […]